Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che-Yuan Wu

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Geroscience|February 25, 2026
Cardiovascular risk factors and vascular neuropathological findings in primary age-related tauopathy versus Alzheimer's diseaseLisa Y Xiong, Myuri Ruthirakuhan, Si Won Ryoo, et al.
Neurobiology of Aging|January 18, 2021
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockersMichael Ouk, Che-Yuan Wu, Jennifer S Rabin, et al.
Psychoneuroendocrinology|October 23, 2021
Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markersMichelle M Nguyen, George Perlman, Nakyung Kim, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 16, 2022
Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentChe-Yuan Wu, Lisa Y Xiong, Michael Ouk, et al.
Journal of Internal Medicine|September 25, 2023
No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetesChe-Yuan Wu, Christa Wang, Refik Saskin, et al.
Alzheimer'S Research & Therapy|February 12, 2021
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusMichael Ouk, Che-Yuan Wu, Jennifer S Rabin, et al.
Molecular Psychiatry|August 5, 2024
Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomesLisa Y Xiong, Madeline Wood Alexander, Yuen Yan Wong, et al.
Neurology|April 3, 2024
Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on AgingMadeline Wood Alexander, Che-Yuan Wu, Gillian T Coughlan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentChe-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Journal of Cardiac Failure|August 1, 2025
Sodium-glucose Cotransporter-2 Inhibitor Initiation and Incident Dementia in Heart Failure With Diabetes: A Population-based Cohort StudyChe-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Geroscience|February 25, 2026
Cardiovascular risk factors and vascular neuropathological findings in primary age-related tauopathy versus Alzheimer's diseaseLisa Y Xiong, Myuri Ruthirakuhan, Si Won Ryoo, et al.
Neurobiology of Aging|January 18, 2021
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockersMichael Ouk, Che-Yuan Wu, Jennifer S Rabin, et al.
Psychoneuroendocrinology|October 23, 2021
Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markersMichelle M Nguyen, George Perlman, Nakyung Kim, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 16, 2022
Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentChe-Yuan Wu, Lisa Y Xiong, Michael Ouk, et al.
Journal of Internal Medicine|September 25, 2023
No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetesChe-Yuan Wu, Christa Wang, Refik Saskin, et al.
Alzheimer'S Research & Therapy|February 12, 2021
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusMichael Ouk, Che-Yuan Wu, Jennifer S Rabin, et al.
Molecular Psychiatry|August 5, 2024
Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomesLisa Y Xiong, Madeline Wood Alexander, Yuen Yan Wong, et al.
Neurology|April 3, 2024
Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on AgingMadeline Wood Alexander, Che-Yuan Wu, Gillian T Coughlan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentChe-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Journal of Cardiac Failure|August 1, 2025
Sodium-glucose Cotransporter-2 Inhibitor Initiation and Incident Dementia in Heart Failure With Diabetes: A Population-based Cohort StudyChe-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Pageof 5